These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2963968)

  • 1. Central serotonergic influences on renal electrolyte and water excretion.
    Stein JM; Lind RW; Johnson AK
    Neuropharmacology; 1987 Dec; 26(12):1685-92. PubMed ID: 2963968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efferent mechanisms mediating renal sodium and water excretion induced by centrally administered serotonin.
    Montes R; Johnson AK
    Am J Physiol; 1990 Dec; 259(6 Pt 2):R1267-73. PubMed ID: 2148061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central stimulation of renin secretion through serotonergic, noncardiovascular mechanisms.
    Rittenhouse PA; Bakkum EA; Levy AD; Li Q; Yracheta JM; Kunimoto K; van de Kar LD
    Neuroendocrinology; 1994 Aug; 60(2):205-14. PubMed ID: 7969778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HT1c/2 receptors.
    Rittenhouse PA; Levy AD; Li Q; Bethea CL; Van de Kar LD
    Endocrinology; 1993 Aug; 133(2):661-7. PubMed ID: 8344205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a role of brain serotonergic neurotransmission in avoidance learning.
    Ogren SO
    Acta Physiol Scand Suppl; 1985; 544():1-71. PubMed ID: 3006431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of the ascending serotonergic system in the stimulation of atrial natriuretic peptide release.
    Reis LC; Ramalho MJ; Favaretto AL; Gutkowska J; McCann SM; Antunes-Rodrigues J
    Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12022-6. PubMed ID: 7991577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenfluramine, p-chloroamphetamine and p-fluoroamphetamine stimulation of pituitary-adrenocortical activity in rat: evidence for differences in site and mechanism of action.
    McElroy JF; Miller JM; Meyer JS
    J Pharmacol Exp Ther; 1984 Mar; 228(3):593-9. PubMed ID: 6323674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment.
    Dewar KM; Grondin L; Carli M; Lima L; Reader TA
    J Neurochem; 1992 Jan; 58(1):250-7. PubMed ID: 1370077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological evidence for a role of brain serotonin in the maintenance of plasma renin activity in unanesthetized rats.
    Van de Kar LD; Wilkinson CW; Ganong WF
    J Pharmacol Exp Ther; 1981 Oct; 219(1):85-90. PubMed ID: 6457138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring 5-hydroxytryptamine release in the brain of the freely moving unanaesthetized rat using in vivo voltammetry.
    Marsden CA; Conti J; Strope E; Curzon G; Adams RN
    Brain Res; 1979 Jul; 171(1):85-99. PubMed ID: 157184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of serotonin-releasing drugs on serum corticosterone concentration in rats.
    Fuller RW; Snoddy HD
    Neuroendocrinology; 1980 Aug; 31(2):96-100. PubMed ID: 6446690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term and long-term effects of p-chloroamphetamine on hippocampal serotonin and corticosteroid receptor levels.
    Novotney S; Lowy MT
    Brain Res; 1995 Jun; 684(1):19-25. PubMed ID: 7583200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin.
    Zavala L; Barbella Y; Israel A
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):39-44. PubMed ID: 15136973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat.
    Curzon G; Fernando JC; Marsden CA
    Br J Pharmacol; 1978 Aug; 63(4):627-34. PubMed ID: 80243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of intracerebroventricular insulin microinjection on renal sodium handling and arterial blood pressure in rats.
    Menegon LF; Zaparolli A; Boer PA; de Almeida AR; Gontijo JA
    Brain Res Bull; 2008 Jul; 76(4):344-8. PubMed ID: 18502308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.
    Callaway CW; Johnson MP; Gold LH; Nichols DE; Geyer MA
    Psychopharmacology (Berl); 1991; 104(3):293-301. PubMed ID: 1924637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests.
    Eide PK; Hole K; Berge OG; Broch OJ
    Brain Res; 1988 Feb; 440(1):42-52. PubMed ID: 2965956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 5,7-dihydroxytryptamine and 6-hydroxydopamine on head-twitch response induced by serotonin, p-chloroamphetamine, and tryptamine in mice.
    Orikasa S; Sloley BD
    Psychopharmacology (Berl); 1988; 95(1):124-31. PubMed ID: 3133691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.
    Kehne JH; McCloskey TC; Taylor VL; Black CK; Fadayel GM; Schmidt CJ
    J Pharmacol Exp Ther; 1992 Jan; 260(1):78-89. PubMed ID: 1731054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of p-chlorophenylalanine at moderate dosage on 5-HT and 5-HIAA concentrations in brain regions of control and p-chloroamphetamine treated rats.
    Datla KP; Curzon G
    Neuropharmacology; 1996 Mar; 35(3):315-20. PubMed ID: 8783206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.